Crucible · Firm report card

Lipella Pharmaceuticals Inc.

PA · SBIR awardee across 1 federal program (HHS/NIH), first award 2006.

14SBIR awards
$10MSBIR $
6 → 8Phase I → II
$0Follow-on federal $
0Follow-on contracts

SBIR awards by program

ProgramAwardsSBIR $Phase IPhase II
HHS/NIH 14 $10M 6 8

Mission areas

Open the interactive profile of Lipella Pharmaceuticals Inc. →

Full award history, follow-on contract detail, and cross-agency comparison in the Crucible app.

Data: SBIR.gov award records + USAspending.gov prime contracts, matched by recipient name. Follow-on dollars are association, not causation — they show where this firm's later federal prime-contract dollars landed, not that SBIR work caused them. Methodology